View Older Stories View More Recent Stories

Oct 24, 2019 07:21AM Amicus Therapeutics (FOLD) Announces Additional Positive Interim Clinical Data for CLN6 Batten Disease Gene Therapy at CNS
Oct 24, 2019 07:00AM Amicus Announces Additional Positive Interim Clinical Data for CLN6 Batten Disease Gene Therapy at 48th Annual Meeting of the Child Neurology Society
Oct 10, 2019 07:33AM Amicus Therapeutics (FOLD) Prelim. Q3 Revenue Tops Views
Oct 10, 2019 07:30AM Amicus Therapeutics Announces Preliminary Third Quarter 2019 Revenue and Financial Outlook at 2019 Analyst Day
Oct 2, 2019 07:04AM Amicus Therapeutics (FOLD) Announces Additional Positive Data in Pompe Disease Phase 1/2 Study of AT-GAA
Oct 2, 2019 07:00AM Amicus Therapeutics Announces Additional Positive Data in Pompe Disease Phase 1/2 Study of AT-GAA at the 24th International Annual Congress of the World Muscle Society
Oct 1, 2019 07:00AM Amicus Therapeutics to Present at Upcoming Medical and Investor Conferences in October 2019
Sep 4, 2019 07:00AM Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2019
Aug 8, 2019 07:00AM Amicus Therapeutics Announces Second Quarter 2019 Financial Results and Corporate Updates
Aug 2, 2019 07:08AM Amicus Therapeutics (FOLD) Receives Marketing Authorization for Galafold for Fabry Disease in Argentina
Aug 2, 2019 07:00AM Amicus Therapeutics Receives Marketing Authorization for Galafold® (migalastat) for Fabry Disease in Argentina
Aug 1, 2019 06:25AM Amicus Therapeutics (FOLD) Announces Positive Interim Clinical Data for AAV Gene Therapy in Children with CLN6 Batten Disease
Aug 1, 2019 06:00AM Amicus Announces Positive Interim Clinical Data for AAV Gene Therapy in Children with CLN6 Batten Disease
Jul 29, 2019 07:00AM Amicus Therapeutics to Announce Second Quarter 2019 Financial Results on August 8, 2019
Jul 2, 2019 07:35AM Amicus Therapeutics (FOLD), Catalent Biologics Enter Strategic Partnership for Gene Therapy Development and Manufacturing
Jul 2, 2019 07:30AM Amicus Therapeutics and Catalent Biologics Enter Strategic Partnership for Gene Therapy Development and Manufacturing
Jul 1, 2019 07:06AM Amicus Therapeutics (FOLD) and Brammer Bio Enter Strategic Gene Therapy Development and Manufacturing Collaboration
Jul 1, 2019 07:00AM Amicus Therapeutics and Brammer Bio, a part of Thermo Fisher Scientific, Enter Strategic Gene Therapy Development and Manufacturing Collaboration
Jun 13, 2019 07:30AM Amicus Therapeutics Adds Key Executives in Gene Therapy Science and Global Commercial Leadership
Jun 3, 2019 07:00AM Amicus Therapeutics to Present at Upcoming Scientific and Investor Conferences
May 13, 2019 05:14PM Amicus Therapeutics (FOLD) Reports Election of Burke W. Whitman to Board
May 13, 2019 05:00PM Amicus Therapeutics Appoints Burke W. Whitman to its Board of Directors
May 10, 2019 07:00AM Amicus Therapeutics to Present at the Bank of America Merrill Lynch 2019 Health Care Conference
May 8, 2019 07:00AM Amicus Therapeutics Announces First Quarter 2019 Financial Results and Corporate Updates
Apr 30, 2019 06:20AM Amicus Therapeutics (FOLD) Highlights Positive Preclinical Pompe Disease Gene Therapy Data at ASGCT Meetings
Apr 30, 2019 06:00AM Amicus Therapeutics Presents Positive Preclinical Pompe Disease Gene Therapy Data at the American Society of Gene & Cell Therapy (ASGCT) 22nd Annual Meeting
Apr 25, 2019 07:00AM Amicus Therapeutics to Announce First Quarter 2019 Financial Results on May 8, 2019
Apr 15, 2019 12:00PM Amicus Therapeutics to Present Preclinical Pompe Disease Gene Therapy Data at the American Society of Gene & Cell Therapy (ASGCT) 22nd Annual Meeting
Mar 20, 2019 07:00AM Amicus Therapeutics Issued Two U.S. Patents for Pompe Enzyme ATB200
Feb 28, 2019 07:00AM Amicus Therapeutics Announces Full-Year 2018 Financial Results and 2019 Corporate Updates
Feb 27, 2019 08:33PM WuXi Biologics Congratulates Amicus on Receiving FDA Breakthrough Therapy Designation for AT-GAA
Feb 26, 2019 07:00AM Amicus Establishes Global Research and Gene Therapy Center of Excellence in Philadelphia
Feb 25, 2019 06:17AM Amicus Therapeutics (FOLD) Says U.S. FDA Granted Breakthrough Therapy Designation to its AT-GAA in Late Onset Pompe Disease
Feb 25, 2019 04:00AM U.S. FDA Grants Breakthrough Therapy Designation (“BTD”) to Amicus’ AT-GAA in Late Onset Pompe Disease
Feb 12, 2019 07:00AM Amicus Therapeutics to Announce Full-Year 2018 Financial Results on February 28, 2019
Feb 11, 2019 07:00PM WuXi Biologics and Amicus Sign Exclusive Manufacturing Partnership
Feb 5, 2019 04:02PM Amicus Therapeutics (FOLD) Announces Positive data in Pompe Disease Phase 1/2 Study for Up to 24 Months
Feb 5, 2019 04:01PM Amicus Therapeutics Announces Positive data in Pompe Disease Phase 1/2 Study for Up to 24 Months at 15th Annual WORLDSymposium™
Jan 18, 2019 07:00AM Amicus Therapeutics Announces Presentations and Posters at 15th Annual WORLDSymposium™ 2019
Jan 7, 2019 07:08AM UPDATE: Amicus Therapeutics (FOLD) Reports Prelim. FY18 Revenues Above Consensus; Provides FY19 Revenue Mid-Point Guidance Below Consensus & Strategic Outlook
Jan 7, 2019 07:00AM Amicus Therapeutics Provides Full-Year 2019 Strategic Outlook and Financial Guidance
Jan 3, 2019 04:01PM Amicus Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference
Jan 3, 2019 07:11AM Amicus Therapeutics (FOLD) Initiates Phase 1/2 Study of Gene Therapy for CLN3 Batten Disease
Jan 3, 2019 07:00AM Amicus Therapeutics Announces Phase 1/2 Study of Gene Therapy for CLN3 Batten Disease
Dec 20, 2018 07:05AM Amicus Therapeutics (FOLD) Reports First Patient Dosed in Phase 3 PROPEL Pivotal Study of AT-GAA in Patients with Pompe Disease
Dec 20, 2018 07:00AM Amicus Therapeutics Announces First Patient Dosed in Phase 3 PROPEL Pivotal Study of AT-GAA in Patients with Pompe Disease
Dec 19, 2018 04:01PM Amicus Therapeutics Announces Executive Team Updates
Dec 11, 2018 04:01PM Amicus Therapeutics Awarded United Kingdom Prix Galien Medal for Galafold® (Migalastat)
Nov 12, 2018 07:00AM Amicus Therapeutics to Present at the Credit Suisse 27th Annual Healthcare Conference
Nov 5, 2018 07:00AM Amicus Therapeutics Announces Third Quarter 2018 Financial Results and Corporate Updates
View More Recent Stories View Older Stories